स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - turoctocogum alfa - injektionspräparat - praeparatio cryodesiccata: turoctocogum alfa 2000 u.i., histidinum, saccharum, polysorbatum 80, natrii chloridum, methioninum, calcii chloridum dihydricum, pro vitro. solvens: natrii chloridum, aqua ad iniectabile, q.s. ad solutionem pro 4 ml. - l'hémophilie a - biotechnologika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - turoctocogum alfa - injektionspräparat - praeparatio cryodesiccata: turoctocogum alfa 3000 u.i., histidinum, saccharum, polysorbatum 80, natrii chloridum, methioninum, calcii chloridum dihydricum, pro vitro. solvens: natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 4 ml. - l'hémophilie a - biotechnologika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - repaglinidum - comprimés - repaglinidum 0.5 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas pro compresso. - antidiabétique oral utilisé - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - repaglinidum - comprimés - repaglinidum 1 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, e 172 (flavum) pro compresso. - antidiabétique oral utilisé - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - repaglinidum - comprimés - repaglinidum 2 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, e 172 (rubrum) pro compresso. - antidiabétique oral utilisé - synthetika

ट्यूनीशिया - फ़्रेंच - Ministère de la Santé, Direction de l'inspection Pharmaceutique

novo nordisk a/s bagsvaerd - insuline analogue - solution injectable - 100 ui/ml - appareil digestif et metabolisme - medicament utilise dans le traitement du diabete - novorapid est indiqué dans le traitement du diabète de l'adulte, de l'adolescent et de l'enfant à partir de 1an.

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 1 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 0.5 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 1.12 ml. solutio reconstituta: eptacogum alfa (activatum) 1 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 2 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 1 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 2.1 ml. solutio reconstituta: eptacogum alfa (activatum) 2 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 5 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 2.5 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 5.17 ml. solutio reconstituta: eptacogum alfa (activatum) 5 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 8 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 4 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 8.3 ml. solutio reconstituta: eptacogum alfa (activatum) 8 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 8 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika